VC Scott Minick Named CEO of BIND Bioscience
Scott Minick has stepped down as a managing director with Arch Venture Partners, in order to become president and CEO of Arch portfolio company BIND Biosciences. In related news, BIND has raised $11 million in third-round funding, from Arch, Flagship Ventures, NanoDimension AG and Polaris Venture Partners.
12 January 2010•3 mins read
